Africure Pharmaceuticals Botswana Pharmaceutical Import Profile — Botswana (DGFT 2022–2026)

Name: Africure Pharmaceuticals Botswana Pharmaceutical Import Records from India — 2 Products, $2.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Africure Pharmaceuticals Botswana — Pharmaceutical Importer Profile (2026) | 2 Products, $2.0M Trade | TransData Nexus

Africure Pharmaceuticals Botswana

Pharmaceutical Importer · Botswana · Antiviral & HIV Medications Focus · $2.0M Total Trade · DGFT Verified

Africure Pharmaceuticals Botswana is a pharmaceutical importer based in Botswana with a total trade value of $2.0M across 2 products in 1 therapeutic categories. Based on 40 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Africure Pharmaceuticals Botswana sources from 2 verified Indian suppliers, with Macleods Pharmaceuticals Limited accounting for 97.1% of imports.

Africure Pharmaceuticals Botswana — Import Portfolio & Supplier Network

Africure Pharmaceuticals Botswana import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Africure Pharmaceuticals Botswana?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Macleods Pharmaceuticals Limited	$1.6M	41	97.1%
Jubilant Generics Limited	$50.0K	1	2.9%

Africure Pharmaceuticals Botswana sources from 2 verified Indian suppliers across .

What Formulations Does Africure Pharmaceuticals Botswana Import?

Formulation	Value	Ships
Lamivudine 300MG + tenofovir disoproxilfumarate 300MG + dolutegravir sodium 50MG tablets ps: 1x30s	$509.0K	11
Lamivudine 300MG + tenofovir disoproxilfumarate 300MG + dolutegravir sodium 50MG tablets ps: 1x30s	$450.0K	9
Emtricitabine 200MG + tenofovir	$150.0K	3
Lamivudine 300MG + tenofovir disoproxilfumarate 300MG + dolutegravir 50MG tablets ps: 1x30s	$150.0K	3
Emtricitabine 200MG & tenofovir disoproxil fumarate 300MG tablets bno.14250162a& 14250163a md.01/25 ed.12/26 ps:1x30s	$100.0K	2
Drugs and pharmaceuticals harmless medicines lamivudine tablets 150	$56.3K	6
Jubazi azithromycin 500MG f c tablets 500MG 15x3 africure bots b n az223004amd 02 23 ed 01	$50.0K	1
Medicines. lamivudine 300MG +	$50.0K	1
Lamivudine 300MG + tenofovir	$50.0K	1
Lamivudine 300MG+tenofovir disoproxil fumarate 300MG+dolutegravir sodium 50MG tablets 1x1700s (8825 pac)	$50.0K	1
Drugs and pharmaceuticals harmlessmedicines lamivudine tablets 150 MG	$49.4K	1
Drugs and pharmaceuticals harmless medicines lamivudine tablets 150 MG	$32.4K	1
Net content 900.4950 kgs lamivudine +	$0	1
Net content (lamivudine 4500.7500 kgs,tenofovir disoproxil fumarate 4500.7500 kgs & dolutegravir sodium 750.1250 kgs)	$0	1

Africure Pharmaceuticals Botswana imports 14 distinct pharmaceutical formulations. Showing top 14 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Tenofovir	Antiviral & HIV Medications	$1.1M	23	0.0%	6
2	Dolutegravir	Antiviral & HIV Medications	$850.0K	17	0.0%	6

Africure Pharmaceuticals Botswana imports 2 pharmaceutical products across 1 categories into Botswana totaling $2.0M.

Africure Pharmaceuticals Botswana — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Africure Pharmaceuticals Botswana Pty Ltd is a pharmaceutical importer and distributor based in Botswana, specializing in the procurement and distribution of finished pharmaceutical formulations. The company operates under the ownership of Africure Pharmaceuticals Limited, a Mauritius-based entity committed to enhancing African healthcare through the establishment of manufacturing assets and technical capabilities across Sub-Saharan Africa. Africure Pharmaceuticals Limited's manufacturing facilities are located in countries such as Cameroon, Côte d'Ivoire, Namibia, Botswana, and India, with distribution subsidiaries in Burkina Faso, Cameroon, and Nigeria.

Africure Pharmaceuticals Botswana plays a pivotal role in the country's pharmaceutical distribution network by importing essential medications, particularly focusing on antiviral and HIV treatments. The company's operations are integral to ensuring the availability of critical medications within Botswana, thereby contributing to the nation's healthcare infrastructure. By sourcing high-quality pharmaceutical products from reputable manufacturers, Africure Pharmaceuticals Botswana addresses the local demand for effective treatments, aligning with Africure Pharmaceuticals Limited's mission to manufacture high-quality essential medication in Africa by Africans for Africa.

2Distribution Network

Africure Pharmaceuticals Botswana's distribution network is strategically designed to ensure efficient delivery of pharmaceutical products across Botswana. The company's warehouse is situated at Plot 1090, Selokwaneng Industrial Site, Tlokweng, Gaborone, Botswana. This central location facilitates streamlined logistics operations, enabling timely distribution to various healthcare facilities and pharmacies throughout the country. While specific details regarding the company's logistics capabilities and geographic coverage beyond Botswana are not publicly disclosed, Africure Pharmaceuticals Limited's broader operations in Sub-Saharan Africa suggest a potential for regional distribution, leveraging its manufacturing facilities in neighboring countries.

3Industry Role

Africure Pharmaceuticals Botswana serves as a key importer and distributor within Botswana's pharmaceutical supply chain. By focusing on the importation of finished pharmaceutical formulations, the company ensures the availability of essential medications, particularly in the antiviral and HIV treatment categories. This role is crucial in addressing the healthcare needs of the population, especially in managing and treating HIV/AIDS, a significant health concern in the region. Through its operations, Africure Pharmaceuticals Botswana contributes to the overall health and well-being of the community by providing access to necessary pharmaceutical products.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Africure Pharmaceuticals Botswana

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Africure Pharmaceuticals Botswana's sourcing strategy exhibits a high degree of concentration, with a total import value of $2.0 million USD from India across 40 shipments. The company's portfolio is entirely focused on two products—Tenofovir and Dolutegravir—both integral to HIV treatment regimens. This concentrated sourcing approach indicates a strategic decision to specialize in these critical medications, ensuring a consistent and reliable supply chain for these essential drugs.

The relationship with its primary supplier, MACLEODS PHARMACEUTICALS LIMITED, is characterized by a substantial volume of transactions, accounting for 97.1% of the total shipments. This high dependency on a single supplier could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent and long-term nature of the relationship may also suggest a stable and mutually beneficial partnership. To mitigate potential risks associated with supplier concentration, Africure Pharmaceuticals Botswana may consider diversifying its supplier base or establishing contingency plans to ensure uninterrupted access to critical medications.

2Supply Chain Resilience

Africure Pharmaceuticals Botswana's supply chain resilience is closely tied to its sourcing strategy from India, particularly from MACLEODS PHARMACEUTICALS LIMITED. The company's focus on two specific formulations—Tenofovir and Dolutegravir—indicates a streamlined supply chain that may benefit from economies of scale and operational efficiencies. However, this specialization also means that any disruptions in the production or delivery of these products could significantly impact the company's ability to meet local demand.

Importing Pharmaceuticals into Botswana — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Botswana

1Regulatory Authority & Framework

In Botswana, the regulation of medicines, medical devices, and cosmetics is overseen by the Botswana Medicines Regulatory Authority (BoMRA). BoMRA is responsible for ensuring that pharmaceutical products meet safety, efficacy, and quality standards before they are imported, distributed, or sold within the country. (bomra.co.bw)

The key legislation governing pharmaceutical imports in Botswana includes the Medicines and Related Substances Act, which outlines the requirements for the registration, importation, and distribution of pharmaceutical products. This act ensures that all medicines available in the market are evaluated for their safety and efficacy. The marketing authorization pathway for Indian generics involves submitting comprehensive documentation to BoMRA, including evidence of product quality, safety, and efficacy, as well as compliance with international standards.

2Import Licensing & GMP

Import licensing requirements in Botswana stipulate that all pharmaceutical products must be registered with BoMRA before they can be imported and distributed. This process involves providing detailed information about the product, including its composition, manufacturing process, and clinical data. Additionally, the importing company must hold a valid wholesale distribution authorization issued by BoMRA, ensuring that they operate in compliance with regulatory standards.

Africure Pharmaceuticals Botswana — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Africure Pharmaceuticals Botswana's focus on antiviral and HIV medications, particularly Tenofovir and Dolutegravir, aligns with the high demand for effective HIV treatments in Botswana. The country has a significant HIV prevalence rate, necessitating a reliable supply of antiretroviral drugs to manage and control the epidemic. By specializing in these therapeutic areas, Africure Pharmaceuticals Botswana addresses a critical public health need, ensuring that patients have access to essential medications.

The market demand for these products is driven by the ongoing efforts to provide comprehensive HIV care, including prevention, treatment, and support services. The government's commitment to improving healthcare infrastructure and the availability of antiretroviral therapies further supports the importation and distribution of these medications. Africure Pharmaceuticals Botswana's product strategy is thus well-aligned with national health priorities and the needs of the population.

2Sourcing Profile

Africure Pharmaceuticals Botswana's sourcing strategy is centered on importing generic formulations of Tenofovir and Dolutegravir from India. This approach allows the company to provide cost-effective alternatives to branded medications, making HIV treatments more accessible to the Botswana population. India's robust pharmaceutical manufacturing sector, known for its adherence to international quality standards, makes it a reliable source for these generic drugs.

Frequently Asked Questions — Africure Pharmaceuticals Botswana

What products does Africure Pharmaceuticals Botswana import from India?

Africure Pharmaceuticals Botswana imports 2 pharmaceutical products across 1 categories. Top imports: Tenofovir ($1.1M), Dolutegravir ($850.0K).

Who supplies pharmaceuticals to Africure Pharmaceuticals Botswana from India?

Africure Pharmaceuticals Botswana sources from 2 verified Indian suppliers. The primary supplier is Macleods Pharmaceuticals Limited (97.1% of imports, $1.6M).

What is Africure Pharmaceuticals Botswana's total pharmaceutical import value?

Africure Pharmaceuticals Botswana's total pharmaceutical import value from India is $2.0M, based on 40 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Africure Pharmaceuticals Botswana focus on?

Africure Pharmaceuticals Botswana imports across 1 categories. The largest: Antiviral & HIV Medications (100.0%).

Get Full Africure Pharmaceuticals Botswana Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.